Michael Kranda - Director, Ptc Therapeutics, Inc
As of March 18, 2015
What is Michael Kranda's Net Worth?
The current estimated net worth of Ptc Therapeutics, Inc's Director, Michael Kranda, is estimated to be about $280.7K . Michael Kranda owns about 2,242 units of Ptc Therapeutics, Inc common stock. In the last year at Ptc Therapeutics, Inc, Michael Kranda has sold an estimated value of $218.83K worth.
What is Michael Kranda's Past Insider Trading?
Michael Kranda's largest sale order was 2,500 units , worth over $182.04K on March 18, 2015. In total, Michael Kranda has made about 4 transactions over a year of their time at Ptc Therapeutics, Inc. Michael Kranda usually trades in March and January, with the busiest year in 2015 and 2014.
Michael Kranda
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Michael Kranda's' Mailing Address?
- Mailing address is C/o Vulcan Ventures Incorporated 505 Fifth Avenue, Suite 900 Seattle WA 98104 WA
What are Ptc Therapeutics, Inc's Past Insider Trades?
Ptc Therapeutics, Inc's most recent insider trade came on June 10, 2022 by Dawn Svoronos who sold 738 units worth $20.07K . In the last 9 years, insiders at Ptc Therapeutics, Inc have sold an estimated value of $159.53M and bought an estimated value of $101.25M worth of shares. Insider trading is most common in January, with the busiest year in 2020. The most active traders at the company are Walter Stuart Peltz, CHIEF EXECUTIVE OFFICER, Gregory Neil Almstead, Chief Technical Ops Officer, and Elliott Mark Boulding, EXEC. VP AND CLO .
PTC THERAPEUTICS, INC. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||